(VIANEWS) – SPBK 1 ØSTLANDET (SPOL.OL), SPAREBANKEN VEST (SVEG.OL), KITRON (KIT.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SPBK 1 ØSTLANDET (SPOL.OL)
37.7% sales growth and 10.09% return on equity
SpareBank 1 Østlandet provides various financial products and services to individuals, businesses, the public sector, clubs, and societies. The company operates through Retail, Corporate, and Organisation Market and Capital Market segments. The Retail segment provides financial services comprising of savings, money transfer, insurance, accident prevention, financing, money transfer, capital, and investment management services. The Corporate segment offers interest rate, currency hedging, and investment related services, as well as insurance services for property. The Organisation Market and Capital Market segment provides risk based advisory solutions to high-net-worth individuals and corporates, as well as engages in foreign currency services. SpareBank 1 Østlandet was founded in 1845 and is headquartered in Hamar, Norway. The company operates as a subsidiary of Sparebankstiftelsen Hedmark.
Earnings Per Share
As for profitability, SPBK 1 ØSTLANDET has a trailing twelve months EPS of kr11.56.
PE Ratio
SPBK 1 ØSTLANDET has a trailing twelve months price to earnings ratio of 10.76. Meaning, the purchaser of the share is investing kr10.76 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.09%.
Sales Growth
SPBK 1 ØSTLANDET’s sales growth is 15.5% for the ongoing quarter and 37.7% for the next.
Yearly Top and Bottom Value
SPBK 1 ØSTLANDET’s stock is valued at kr124.40 at 17:20 EST, way under its 52-week high of kr143.00 and way above its 52-week low of kr104.00.
Volume
Today’s last reported volume for SPBK 1 ØSTLANDET is 9511 which is 81.71% below its average volume of 52025.
More news about SPBK 1 ØSTLANDET.
2. SPAREBANKEN VEST (SVEG.OL)
32.1% sales growth and 13.51% return on equity
Sparebanken Vest, a financial services company, provides banking and financing services in the counties of Vestland and Rogaland, Norway. The company operates through Corporate Market, Retail Market, Bulder Bank, Treasury, and Estate Agency Activities segments. It is also involved in home mortgage activities. The company was founded in 1823 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN VEST has a trailing twelve months EPS of kr10.31.
PE Ratio
SPAREBANKEN VEST has a trailing twelve months price to earnings ratio of 9.63. Meaning, the purchaser of the share is investing kr9.63 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.51%.
Sales Growth
SPAREBANKEN VEST’s sales growth is 32.5% for the present quarter and 32.1% for the next.
More news about SPAREBANKEN VEST.
3. KITRON (KIT.OL)
15% sales growth and 21% return on equity
Kitron ASA operates as an electronics manufacturing services company in Norway, Sweden, rest of Europe, the United States, and internationally. It manufactures electronics that are embedded in the customers' products; and box-built electronic products. The company's services include development services, such as product development, product management, and re-engineering services; and industrialization services, including prototype manufacturing, evaluation of new products, component engineering and database, test development, design and build of high level assembly lines, and environmental durability testing. Its services also comprise sourcing and procurement services; manufacturing, assembling, and testing of electronic products for the professional market; redesign, repair, and maintenance; and logistics and distribution services. The company was incorporated in 1996 and is headquartered in Billingstad, Norway.
Earnings Per Share
As for profitability, KITRON has a trailing twelve months EPS of kr1.4.
PE Ratio
KITRON has a trailing twelve months price to earnings ratio of 28.68. Meaning, the purchaser of the share is investing kr28.68 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
KITRON’s EBITDA is 39.74.
More news about KITRON.
4. NAVAMEDIC (NAVA.OL)
9.6% sales growth and 16.31% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr0.45.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 83.33. Meaning, the purchaser of the share is investing kr83.33 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.
More news about NAVAMEDIC.
5. PERNOD RICARD (RI.PA)
7.9% sales growth and 14.84% return on equity
Pernod Ricard SA produces and sells wines and spirits worldwide. The company offers whiskey, vodka, gin, rum, liqueur and bitters, champagne, tequila and mezcal, and aperitif under the brands 100 Pipers, Aberlour, Absolut, Absolut Elyx, Altos, ARARAT, Augier, Avion, Ballantine's, Becherovka, Beefeater, Blenders Pride, Brancott Estate, Campo Viejo, Ceder's, Chivas, Church Road, Clan Campbell, Del Maguey, George Wyndham, Green Spot, Havana Club, Imperial, Imperial Blue, Italicus, J.P. Wiser's, Jacob's Creek, Jameson, Jefferson's, Kahlúa, Kenwood, KI NO BI, Lillet, Long John, L'Orbe, Lot No. 40, Malfy, Malibu, Martell, Method & Madness, Midleton Very Rare, Minttu, Monkey 47, Mumm, Olmeca, Ostoya, Passport Scotch, Pastis 51, Pernod, Perrier-Jouët, Plymouth Gin, Powers, Rabbit Hole, Ramazzotti, Redbreast, Ricard, Royal Salute, Royal Stag, Scapa, Seagram's Gin, Secret Speyside, Smooth Ambler, Something Special, St Hugo, Stoneleigh, Suze, The Glenlivet, TX, Wyborowa, and Ysios. It also provides non-alcoholic beverages under the brands Ceder's, Suze Tonic 0%, Cinzano Spritz 0%, Pacific, Campo Viejo Sparkling 0%, and Jacob's Creek Unvined. The company was founded in 1805 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, PERNOD RICARD has a trailing twelve months EPS of €9.27.
PE Ratio
PERNOD RICARD has a trailing twelve months price to earnings ratio of 22.22. Meaning, the purchaser of the share is investing €22.22 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.84%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.4%, now sitting on 11.86B for the twelve trailing months.
More news about PERNOD RICARD.
